Specification :

Dopexamine hydrochloride (Anti-heart failure drugs cas:86484-91-5)
Pharmacodynamics: A new synthesis of catecholamines and dopamine drug chemical structure similar to a strong ²2-adrenergic receptor stimulant, but the DA1 and DA2 dopamine receptors, as well as the ²1-adrenergic receptor excited about the role of the weak; yet can inhibit the neuronal uptake of catecholamines. This product is the frequency of positive role and the role of positive inotropic drugs indirectly excited through the ²1 adrenergic receptor, to enhance the baroreceptor reflex activity, inhibition of norepinephrine reuptake, as well as the heart of the direct excited ²2-adrenergic receptor generated. This product can increase in kidney, heart and skeletal muscle blood flow.
Clinical Application: Apply to acute heart failure and cardiac output after cardiac surgery patients with low
Usage: Intravenous drip: for acute heart failure and after heart surgery patients to improve hemodynamics, intravenous drip started 0.5¼g/kg. min, after the hemodynamic changes can be increased 1.0¼g/kg. min, up to 6.0¼g/kg. min.
Injection: 50mg: 5ml / support.